Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
PRME | Prime Medicine, Inc. | Exhibit 24 - Power of Attorney; Title: President and Chief Executive Officer, Director | $19M | May 8, 2025 | ||
ICPT | INTERCEPT PHARMACEUTICALS, INC. | Director | Nov 8, 2023 | |||
SEPN | Septerna, Inc. | Director | Sep 25, 2025 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|